Potential 18F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase

This publication has 19 references indexed in Scilit:

• Tyrosine Kinase Inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(Phenylamino)pyrido[d]pyrimidine Acrylamides as Irreversible Inhibitors of the ATP Binding Site of the Epidermal Growth Factor Receptor
  Journal of Medicinal Chemistry, 1999
• Epidermal Growth Factor Radiopharmaceuticals: ¹¹¹In Chelation, Conjugation to a Blood-Brain Barrier Delivery Vector via a Biotin-Polyethylene Linker, Pharacokinetics, and in Vivo Imaging of Experimental Brain Tumors
  Bioconjugate Chemistry, 1999
• Radiolabeling of Epidermal Growth Factor with ^99mTc and in Vivo Localization following Intracerebral Injection into Normal and Glioma-Bearing Rats
  Bioconjugate Chemistry, 1997
• Tyrphostins IV—Highly potent inhibitors of EGF receptor kinase. Structure-activity relationship study of 4-anilidoquinazolines
  Bioorganic & Medicinal Chemistry, 1996
• Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth factor receptor.
  Journal of Medicinal Chemistry, 1995
• Tyrosine Kinase Inhibition: An Approach to Drug Development
  Science, 1995
• Tissue distribution of 131I-labelled epidermal growth factor in the pig visualized by dynamic scintigraphy
  Journal of Endocrinology, 1995
• A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase
  Science, 1994
• Phase I and Imaging Trial of Indium 111-Labeled Anti-Epidermal Growth Factor Receptor Monoclonal Antibody 225 in Patients With Squamous Cell Lung Carcinoma
  JNCI Journal of the National Cancer Institute, 1991
• Imaging of Human Tumor Xenografts With an Indium-111-Labeled Anti-Epidermal Growth Factor Receptor Monoclonal Antibody
  JNCI Journal of the National Cancer Institute, 1989